We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$1.08B
Cap. Flow
+$1.18B
Cap. Flow %
16.06%
Top 10 Hldgs %
55.65%
Holding
321
New
63
Increased
80
Reduced
61
Closed
90

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$101M
2
ICLR icon
Icon
ICLR
+$97.6M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$87.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$82.5M
5
GSK icon
GSK
GSK
+$66.7M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$40.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$36.7M
3
SHAK icon
Shake Shack
SHAK
+$32.9M
4
INCY icon
Incyte
INCY
+$30.5M
5
CYTK icon
Cytokinetics
CYTK
+$30.4M

Sector Composition

Rank Sector Weight
1 Healthcare 39.34%
2 Consumer Discretionary 6.39%
3 Consumer Staples 5.37%
4 Technology 5.27%
5 Communication Services 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
26
Medtronic
MDT
$112B
$59.9M 0.82%
750,164
+114,236
+18% +$9.89M
AUPH icon
27
Aurinia Pharmaceuticals
AUPH
$2.11B
$57.5M 0.78%
6,400,000
-1,800,000
-22% -$14.7M
OFIX icon
28
Orthofix Medical
OFIX
$419M
$52.4M 0.71%
3,000,000
-768,000
-20% -$13.4M
KURA icon
29
Kura Oncology
KURA
$850M
$50.5M 0.69%
5,800,000
+3,142,000
+118% +$45.2M
SPB icon
30
Spectrum Brands
SPB
$2.07B
$48.7M 0.66%
575,857
+80,857
+16% +$7.32M
SMPL icon
31
Simply Good Foods
SMPL
$982M
$46.2M 0.63%
1,185,274
-225,846
-16% -$8.27M
TMCI icon
32
Treace Medical Concepts
TMCI
$309M
$46.2M 0.63%
6,209,000
+13,000
+0.2% +$87K
IRWD icon
33
Ironwood Pharmaceuticals
IRWD
$714M
$41.9M 0.57%
9,468,000
+1,268,000
+15% +$5.14M
S icon
34
SentinelOne
S
$7.34B
$41.1M 0.56%
1,851,178
+457,982
+33% +$11.7M
AMZN icon
35
Amazon
AMZN
$2.96T
$40.6M 0.55%
185,102
+74,590
+67% +$15.3M
MSFT icon
36
Microsoft
MSFT
$3.71T
$40.4M 0.55%
95,966
+48,001
+100% +$20.4M
GOOGL icon
37
Alphabet (Google) Class A
GOOGL
$4.33T
$40.1M 0.55%
211,888
+87,181
+70% +$15.3M
SAM icon
38
Boston Beer
SAM
$1.92B
$36.6M 0.5%
121,929
+26,122
+27% +$7.88M
IMCR icon
39
Immunocore
IMCR
$1.73B
$35.4M 0.48%
1,200,000
-64,000
-5% -$2.02M
ENR icon
40
Energizer
ENR
$1.55B
$34.5M 0.47%
989,426
+637,832
+181% +$22.1M
IMVT icon
41
CALL
Immunovant
IMVT
$8.25B
$33.4M 0.46%
1,350,000
+770,000
+133% +$21.8M
PRTA icon
42
Prothena Corp
PRTA
$450M
$31M 0.42%
2,236,000
+586,000
+36% +$9.24M
MDGL icon
43
Madrigal Pharmaceuticals
MDGL
$11.8B
$30.9M 0.42%
100,000
+50,085
+100% +$14.1M
GEHC icon
44
GE HealthCare
GEHC
$32.4B
$30.8M 0.42%
394,311
+205,398
+109% +$17.5M
BCYC
45
Bicycle Therapeutics
BCYC
$292M
$30.7M 0.42%
2,196,000
+240,000
+12% +$5.14M
VYGR icon
46
Voyager Therapeutics
VYGR
$201M
$30.6M 0.42%
5,396,000
+196,000
+4% +$1.26M
HUBS icon
47
HubSpot
HUBS
$10.5B
$30.3M 0.41%
43,481
+7,333
+20% +$4.71M
ADBE icon
48
Adobe
ADBE
$105B
$30.2M 0.41%
68,012
+36,630
+117% +$18.1M
MNST icon
49
Monster Beverage
MNST
$88.5B
$29.9M 0.41%
569,431
+550,863
+2,967% +$29.2M
WDAY icon
50
Workday
WDAY
$44.4B
$29.6M 0.4%
114,706
+28,538
+33% +$7.29M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Armistice Capital held 321 positions worth $7.33B, up 17% from $6.25B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital deployed $1.18B of net new capital in Q4 2024, opening 63 new positions and adding to 80 existing holdings. Its largest new stake was Exact Sciences: 1,617,000 shares worth $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $36.7M trimmed.

  • Armistice Capital's largest Q4 2024 buy was Exact Sciences: 1,617,000 shares worth $90.9M.
  • Armistice Capital added most to Neurocrine Biosciences in Q4 2024, an estimated $87.9M increase.
  • Armistice Capital's biggest Q4 2024 reduction was PTC Therapeutics, cutting an estimated $36.7M.
  • Armistice Capital fully exited Alkermes in Q4 2024, selling an estimated $40.5M.
  • Armistice Capital's ten largest holdings make up 56% of its $7.33B portfolio in Q4 2024.
  • Armistice Capital opened 63 new positions and closed 90 in Q4 2024.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.